The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2016 | Definitions of smouldering myeloma and when to treat
Antonio Palumbo, MD, from the University of Turin, Turin, Italy provides treatment advice for smouldering myeloma. The key message, according to Dr Palumbo, is that today, smouldering myeloma is defined by the presence of 3g/dL of M-component and at least 10% bone marrow plasma cells. Further, Dr Palumbo discusses ultra high-risk smouldering myeloma and high-risk smouldering myeloma.
Recorded at the 2016 World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.
